The Pathogen-Derived Aminoglycoside Resistance 16S RRNA Methyltransferase NpmA Possesses Dual M1A1408/m1G1408 Specificity
Overview
Affiliations
Chemical modification of 16S rRNA can confer exceptionally high-level resistance to a diverse set of aminoglycoside antibiotics. Here, we show that the pathogen-derived enzyme NpmA possesses dual m(1)A1408/m(1)G1408 activity, an unexpected property apparently unique among the known aminoglycoside resistance 16S rRNA (m(1)A1408) methyltransferases. Although the biological significance of this activity remains to be determined, such mechanistic variation in enzymes acquired by pathogens has significant implications for development of inhibitors of these emerging resistance determinants.
50S subunit recognition and modification by the ribosomal RNA methyltransferase TlyA.
Laughlin Z, Nandi S, Dey D, Zelinskaya N, Witek M, Srinivas P Proc Natl Acad Sci U S A. 2022; 119(14):e2120352119.
PMID: 35357969 PMC: 9168844. DOI: 10.1073/pnas.2120352119.
Aminoglycoside Resistance: Updates with a Focus on Acquired 16S Ribosomal RNA Methyltransferases.
Wachino J, Doi Y, Arakawa Y Infect Dis Clin North Am. 2020; 34(4):887-902.
PMID: 33011054 PMC: 10927307. DOI: 10.1016/j.idc.2020.06.002.
Singh R, Feller A, Roovers M, Van Elder D, Wauters L, Droogmans L RNA. 2018; 24(8):1080-1092.
PMID: 29848639 PMC: 6049504. DOI: 10.1261/rna.064345.117.
Vinal K, Conn G Antimicrob Agents Chemother. 2017; 61(5).
PMID: 28289026 PMC: 5404524. DOI: 10.1128/AAC.00077-17.